Drug Trial Radar · NCT02174627
Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
Last checked: Nov 19, 2026Latest source record: Dec 16, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,781
Actual
Start
Jun 26, 2014
Primary completion
Oct 4, 2018
Study completion Oct 4, 2018
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Kyntra Bio
- First posted
- Jun 25, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the safety and efficacy of roxadustat for treatment of anemia in patients with chronic kidney disease not on dialysis
Conditions
- Anemia
Interventions
RoxadustatDrug
The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.
PlaceboDrug
The initial study drug dose is 70 mg three times a week (TIW). The dose is subsequently adjusted to achieve and maintain Hb 11±1 g/dL.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Hb Averaged Over Week 28 to Week 52Time frame: Baseline (Day 1, Week 0) and Week 28 to Week 52.
Locations
359 sites in 26 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Huntsville, Alabama
Research Site
Phoenix, Arizona
Research Site
Bakersfield, California
Research Site
El Centro, California
Research Site
Escondido, California
Research Site
Glendale, California
Research Site
Long Beach, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Lynwood, California
Research Site
National City, California
Research Site
Northridge, California
Research Site
Orange, California
Research Site
Sacramento, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Dimas, California
Research Site
San Francisco, California
Research Site
San Luis Obispo, California
Research Site
Upland, California
Research Site
Arvada, Colorado
Research Site
Waterbury, Connecticut
Research Site
Aventura, Florida
Research Site
Coral Gables, Florida
Research Site
Coral Springs, Florida
Research Site
Edgewater, Florida
Research Site
Hollywood, Florida
Research Site
Kissimmee, Florida
Research Site
Lauderdale Lakes, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Port Charlotte, Florida
Showing 40 of 359 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.